From July 9, 2013 to October 9, 2013, the company has repurchased 166,483 shares, for KRW 1,007.08 million. With this, the company has completed the repurchase of 166,483 shares, representing 2.25% for KRW 1,007.08 million under the buyback announced on July 9, 2013.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27,900 KRW | -2.28% | -3.12% | +7.93% |
2023 | NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2019 | NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.93% | 162M | |
-9.01% | 236B | |
0.00% | 19.63B | |
+14.16% | 18.91B | |
+9.78% | 11.42B | |
-21.01% | 8.4B | |
+3.10% | 6.62B | |
+1.62% | 5.47B | |
-7.05% | 3.84B | |
-20.94% | 3.66B |
- Stock Market
- Equities
- A092730 Stock
- News NeoPharm CO., LTD.
- Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on July 9, 2013